O
OrbiMed’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 117 |
|
|
2025
Q1 | – | Sell |
-372,000
| Closed | -$33.5M | – | 120 |
|
|
2024
Q4 | $33.5M | Buy |
+372,000
| New | +$33.5M | 0.69% | 40 |
|
|
2023
Q2 | – | Sell |
-274,000
| Closed | -$20.9M | – | 129 |
|
|
2023
Q1 | $20.9M | Buy |
274,000
+197,600
| +259% | +$15.1M | 0.41% | 65 |
|
|
2022
Q4 | $6.34M | Hold |
76,400
| – | – | 0.12% | 86 |
|
|
2022
Q3 | $6.06K | Sell |
76,400
-35,400
| -32% | -$2.81K | 0.11% | 100 |
|
|
2022
Q2 | $8.3K | Hold |
111,800
| – | – | 0.15% | 98 |
|
|
2022
Q1 | $10M | Sell |
111,800
-897,900
| -89% | -$80.7M | 0.16% | 101 |
|
|
2021
Q4 | $113M | Sell |
1,009,700
-56,000
| -5% | -$6.27M | 1.45% | 25 |
|
|
2021
Q3 | $134M | Buy |
1,065,700
+130,000
| +14% | +$16.3M | 1.47% | 21 |
|
|
2021
Q2 | $127M | Buy |
+935,700
| New | +$127M | 1.28% | 25 |
|
|
2020
Q2 | – | Sell |
-127,200
| Closed | -$9.85M | – | 153 |
|
|
2020
Q1 | $9.85M | Hold |
127,200
| – | – | 0.17% | 86 |
|
|
2019
Q4 | $12.1M | Buy |
+127,200
| New | +$12.1M | 0.17% | 76 |
|
|
2016
Q3 | – | Sell |
-745,300
| Closed | -$40.3M | – | 144 |
|
|
2016
Q2 | $40.3M | Sell |
745,300
-235,900
| -24% | -$12.8M | 0.42% | 55 |
|
|
2016
Q1 | $50.7M | Buy |
+981,200
| New | +$50.7M | 0.53% | 47 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 116 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 114 |
|